Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02801084 · ClinicalTrials.gov registry record · NA

Effects of Reduced Environmental Stimulation on Eating Disorders

A NA study of Anorexia Nervosa, sponsored by Laureate Institute for Brain Research.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT02801084: Completed NA study of Anorexia Nervosa, sponsored by Laureate Institute for Brain Research.

NCT02801084 is a NA study of Anorexia Nervosa that has completed, run by Laureate Institute for Brain Research. The registered enrollment target is 21 participants, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02801084, a NA study of Anorexia Nervosa, has completed, sponsored by Laureate Institute for Brain Research.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The study proposed in this protocol aims to document the physiological, subjective, behavioral, and neural effects of reduced environmental stimulation (floating) in patients with current or prior anorexia nervosa The primary aim of this study is to determine the safety of this intervention. Secondary aims including determining whether floating has an impact on symptom reports such as those related to anxiety and eating disorders.

Primary Outcome

Defined as a drop of ≥20 mm Hg in systolic blood pressure or a drop of ≥10 mm Hg in diastolic blood pressure when measured shortly after transitioning from lying down to standing.

Conditions Studied

Interventions

  • BEHAVIORAL Reduced environmental stimulation

Study Locations (1)

Oklahoma

  • Laureate Institute for Brain Research - Tulsa

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2016-04
Est. Completion 2017-10-19
Phase NA

What the finished NCT02801084 record still lists

NCT02801084 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Reduced environmental stimulation is the first listed.

NCT02801084 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT02801084 about?

NCT02801084 is a clinical study titled "Effects of Reduced Environmental Stimulation on Eating Disorders". The study proposed in this protocol aims to document the physiological, subjective, behavioral, and neural effects of reduced environmental stimulation (floating) in patients with current or prior anorexia nervosa The primary aim of this study is to determine the safety of this intervention. Seconda...

What is the current status of trial NCT02801084?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-04. Estimated completion is 2017-10-19.

What conditions does trial NCT02801084 study?

This clinical trial studies the following conditions: Anorexia Nervosa.

What interventions are being tested in trial NCT02801084?

The interventions under investigation include: Reduced environmental stimulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02801084?

This trial is sponsored by Laureate Institute for Brain Research, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02801084 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02801084's enrollment target sits among peer trials

21 34th of 43 higher than 10 of 43 other Anorexia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02801084, the US trial registry maintained by the National Library of Medicine. NCT02801084 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.